A new clinical guideline from the American Society for Radiation Oncology (ASTRO) focuses on the use of radiation therapy to treat adult patients with World Health Organization (WHO) grade 4 diffuse gliomas, a category that includes some of the most common and most aggressive primary brain tumors. The guideline, which replaces ASTRO’s 2016 guideline for glioblastoma, is published in Practical Radiation Oncology.

The factors that go into optimizing athletic performance have long been of interest to trainers, scientists, and, of course, athletes themselves. These include workout regimens, nutrition, and technique. A team of psychology researchers has now uncovered a more basic influence on success: visual attention. In an investigation of nearly 1,600 runners, scientists found that narrowing visual attention—zooming in on the finish rather than taking in the surroundings—serves as a powerful self-regulation strategy that can boost both effort and performance. 

In the midst of a multi-state measles outbreak, a new poll by Harvard T.H. Chan School of Public Health and the de Beaumont Foundation finds that most U.S. adults (79%) say parents should be required to have children vaccinated against preventable diseases like measles, mumps, and rubella to attend school. This includes a majority of adults across party lines – 90% among Democrats and 68% among Republicans – as well as 66% of those who support the “Make America Great Again” (MAGA) movement. It also includes 72% of all parents. Among all U.S. adults, about one in five (21%) do not support routine childhood vaccine requirements.

An international team led by Ca’ Foscari University of Venice has successfully transformed common brewer’s yeast microorganisms into micro fluorescent factories, each able to produce a unique peptide with potential therapeutic uses. The research was published today in Nature Communications

A new gene therapy delivery device could let hospital pharmacies make personalized nanomedicines to order. This democratized approach to precision medicine, as published in Frontiers in Science, could revolutionize how hospitals treat rare diseases, even in low-resource settings.